These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38745948)

  • 41. WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type.
    Andikyan V; Taylor HS
    J Cell Mol Med; 2009; 13(11-12):4522-31. PubMed ID: 19017365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome.
    Zhou R; Li S; Liu J; Wu H; Yao G; Sun Y; Chen ZJ; Li W; Du Y
    EBioMedicine; 2020 Feb; 52():102635. PubMed ID: 32028069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endometrial function in women with polycystic ovary syndrome: a comprehensive review.
    Palomba S; Piltonen TT; Giudice LC
    Hum Reprod Update; 2021 Apr; 27(3):584-618. PubMed ID: 33302299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgens and endometrium: New insights and new targets.
    Simitsidellis I; Saunders PTK; Gibson DA
    Mol Cell Endocrinol; 2018 Apr; 465():48-60. PubMed ID: 28919297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candidate genes for polycystic ovary syndrome are regulated by TGFβ in the bovine foetal ovary.
    Azumah R; Liu M; Hummitzsch K; Bastian NA; Hartanti MD; Irving-Rodgers HF; Anderson RA; Rodgers RJ
    Hum Reprod; 2022 May; 37(6):1244-1254. PubMed ID: 35413103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear factor-κB expression in the endometrium of normal and overweight women with polycystic ovary syndrome.
    Koc O; Ozdemirici S; Acet M; Soyturk U; Aydin S
    J Obstet Gynaecol; 2017 Oct; 37(7):924-930. PubMed ID: 28617068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of GPR30, ERα and ERβ in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study.
    Wang A; Ji L; Shang W; Li M; Chen L; White RE; Han G
    Gynecol Endocrinol; 2011 Apr; 27(4):251-5. PubMed ID: 21269226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide analysis of histone modifications in human endometrial stromal cells.
    Tamura I; Ohkawa Y; Sato T; Suyama M; Jozaki K; Okada M; Lee L; Maekawa R; Asada H; Sato S; Yamagata Y; Tamura H; Sugino N
    Mol Endocrinol; 2014 Oct; 28(10):1656-69. PubMed ID: 25073104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?
    Hartanti MD; Rosario R; Hummitzsch K; Bastian NA; Hatzirodos N; Bonner WM; Bayne RA; Irving-Rodgers HF; Anderson RA; Rodgers RJ
    PLoS One; 2020; 15(2):e0229351. PubMed ID: 32078641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases.
    Xiong F; Xiao J; Bai Y; Zhang Y; Li Q; Lishuang X
    Biomed Pharmacother; 2019 Jan; 109():1578-1585. PubMed ID: 30551411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of autophagy gene expression in endometria from women with polycystic ovary syndrome.
    Sumarac-Dumanovic M; Apostolovic M; Janjetovic K; Jeremic D; Popadic D; Ljubic A; Micic J; Dukanac-Stamenkovic J; Tubic A; Stevanovic D; Micic D; Trajkovic V
    Mol Cell Endocrinol; 2017 Jan; 440():116-124. PubMed ID: 27845161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of a hyperandrogenaemic state on the proliferation and decidualization potential in human endometrial stromal cells.
    Freis A; Renke T; Kämmerer U; Jauckus J; Strowitzki T; Germeyer A
    Arch Gynecol Obstet; 2017 Apr; 295(4):1005-1013. PubMed ID: 28168653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bromodomain-containing protein 4 activates androgen receptor transcription and promotes ovarian fibrosis in PCOS.
    Wang D; Zhu Z; Fu Y; Zhang Q; Zhang Y; Wang T; Weng Y; Wen Y; Cao W; Tao G; Wang Y
    Cell Rep; 2023 Sep; 42(9):113090. PubMed ID: 37669164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced expression of Il10, Stat3, Hoxa10, and Itgb3 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
    Changaei M; Javidan M; Ramezani Tehrani F; Mosaffa N; Noroozzadeh M; Hosseinzadeh R; Rajaei S
    Am J Reprod Immunol; 2023 Jul; 90(1):e13702. PubMed ID: 37062956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS).
    Rivero R; Garin CA; Ormazabal P; Silva A; Carvajal R; Gabler F; Romero C; Vega M
    Reprod Biol Endocrinol; 2012 Mar; 10():17. PubMed ID: 22390153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome.
    Maliqueo M; Clementi M; Gabler F; Johnson MC; Palomino A; Sir-Petermann T; Vega M
    Fertil Steril; 2003 Sep; 80 Suppl 2():812-9. PubMed ID: 14505758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations of endometrial epithelial-mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro.
    Hu M; Zhang Y; Li X; Cui P; Li J; Brännström M; Shao LR; Billig H
    Mol Hum Reprod; 2020 May; 26(5):312-326. PubMed ID: 32202622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome.
    Atiomo W; Shafiee MN; Chapman C; Metzler VM; Abouzeid J; Latif A; Chadwick A; Kitson S; Sivalingam VN; Stratford IJ; Rutland CS; Persson JL; Ødum N; Fuentes-Utrilla P; Jeyapalan JN; Heery DM; Crosbie EJ; Mongan NP
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):557-565. PubMed ID: 28748640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.